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The influenza M2 protein not only forms a proton channel but also
mediates membrane scission in a cholesterol-dependent manner to
cause virus budding and release. The atomic interaction of cholesterol
with M2, as with most eukaryotic membrane proteins, has long been
elusive. We have now determined the cholesterol-binding site of the
M2 protein in phospholipid bilayers using solid-state NMR spectros-
copy. Chain-fluorinated cholesterol was used to measure cholesterol
proximity to M2 while sterol-deuterated cholesterol was used to
measure bound-cholesterol orientation in lipid bilayers. Carbon–fluo-
rine distance measurements show that at a cholesterol concentration
of 17 mol%, two cholesterol molecules bind each M2 tetramer. Cho-
lesterol binds the C-terminal transmembrane (TM) residues, near an
amphipathic helix, without requiring a cholesterol recognition se-
quencemotif. DeuteriumNMR spectra indicate that bound cholesterol
is approximately parallel to the bilayer normal, with the rough face of
the sterol rings apposed tomethyl-rich TM residues. The distance- and
orientation-restrained cholesterol-binding site structure shows that
cholesterol is stabilized by hydrophobic interactions with the TM helix
and polar and aromatic interactions with neighboring amphipathic
helices. At the 1:2 binding stoichiometry, lipid 31P spectra show an
isotropic peak indicative of high membrane curvature. This M2–cho-
lesterol complex structure, together with previously observed M2
localization at phase boundaries, suggests that cholesterol mediates
M2 clustering to the neck of the budding virus to cause the necessary
curvature for membrane scission. The solid-state NMR approach de-
veloped here is generally applicable for elucidating the structural ba-
sis of cholesterol’s effects on membrane protein function.
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Cholesterol plays important roles in membrane protein func-tions such as neurotransmission and ion transport (1–4).
Cholesterol can affect protein structure by indirectly modulating the
physical properties of the lipid membrane or by direct and site-
specific binding. Which mechanism is operative and the details
of the mechanism have been elusive due to the scarcity of high-
resolution structures of membrane proteins in cholesterol-containing
lipid membranes, except for adventitious capturing of cholesterol
in crystal structures of membrane proteins (5). A number of
cholesterol-binding amino acid sequence motifs have been pro-
posed, including a two-helix cholesterol consensus motif (CCM) in
G-protein–coupled receptors (5) and a single-helix cholesterol
recognition amino acid consensus (CRAC) motif and its inverted
counterpart CARC (6, 7). These motifs share the common feature
of a branched hydrophobic residue, an aromatic residue, and a
positively charged residue. The spacing between these residues is
variable in CRAC and CARC motifs but is strictly defined in the
CCM. The CCM additionally includes a second aromatic residue
from a neighboring transmembrane (TM) helix. Due to the scar-
city of high-resolution structural information, only the CCM has
been observed (5), which reduces the predictive power of the
loosely defined CRAC and CARC cholesterol-binding motifs (7).
The influenza M2 protein mediates membrane scission in the
last step of virus budding in a cholesterol-dependent fashion: in
membranes with less than ∼23 mol% cholesterol, M2 causes
budding of giant unilamellar vesicles (GUVs) (8). The domain
responsible for membrane scission is an amphipathic helix (AH)
(8) that is C-terminal to the TM domain. M2 isolated from virus-
infected cells copurifies with cholesterol at a ratio of 0.5–0.9 cho-
lesterol per protein monomer (9). Cholesterol also modulates
drug binding to the TM pore to block its proton channel activity
(10–13). A cholesterol-binding CRAC motif has been proposed
for the majority of M2 sequences (14). Located in the amphipathic
helix, this CRAC motif consists of a Leu, Tyr, and a cationic Arg
or Lys (Fig. 1A). However, 2% of M2 sequences, including the
1968 pandemic flu M2 and the commonly studied Udorn M2, lack
the CRAC motif without adverse consequences to virus assembly
and replication (15, 16) or proton channel activity (9). In fact, the
membrane scission activity was first observed in Udorn M2, which
lacks the complete CRAC motif. Deletion of the CRAC motif in
the M2 sequence from the 1933 WSN H1N1 strain did not affect
in vitro virus replication but attenuated virulence in a mouse
model (15). Recently, a solid-state NMR (SSNMR) study de-
tected cholesterol–M2 cross-peaks (11) but was unable to assign
the cross-peaks to a specific residue. Thus, whether the CRAC
motif is required for M2–cholesterol interaction, and whether
cholesterol binds a specific site in the protein, remain unknown.
To elucidate atomic details of cholesterol interaction with M2,
we have now determined the cholesterol-binding site of M2 and
bound-cholesterol orientation in phospholipid bilayers using
magic-angle–spinning (MAS) SSNMR. M2 peptides containing
various 13C,15N-labeled residues were reconstituted into 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine (POPC):1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphatidylglycerol (POPG) bilayers that contain
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17 mol% cholesterol, a composition that has been shown by con-
focal and electron microscopy to permit membrane budding (8). By
measuring protein–cholesterol distances, we show that cholesterol
binds at a unique site of M2. Comparing M2 sequences with and
without the amphipathic helix, and with and without the CRAC
motif, we show that cholesterol binding requires the amphipathic
helix but not the CRAC motif. Furthermore, we used 2H NMR to
measure the orientation of bound cholesterol. The resulting struc-
tural model of the cholesterol-binding site of M2 gives molecular
insight into how M2 co-opts cholesterol to carry out membrane
scission and mediate virus release.
Results
Protein Sequence Requirements for Cholesterol Binding. To measure
cholesterol–M2 proximity, we combined chain-heptafluorinated
cholesterol (F7-cholesterol, Fig. 1B) with
13C-labeled protein and
conducted 13C–19F rotational-echo–double-resonance (REDOR)
distance measurements (17–19) (Fig. S1). F7-cholesterol has the
same interfacial area, molecular orientation, and phospholipid in-
teraction as hydrogenated cholesterol based on pressure-area iso-
therm data (20). Six residues on the lipid-facing surface and helix–
helix interface of the TM domain were 13C-labeled for the distance
experiments (Fig. 1C and Table S1). M2 peptides (residues 22–61)
corresponding to the CRAC-containing Weybridge strain (M2W)
and the CRAC-absent Udorn strain (M2U) were synthesized. The
13C chemical shifts of the labeled residues are well resolved (Fig. 2),
thus allowing Cα distances to F7-cholesterol to be measured and
compared. In both M2W and M2U TM-AH peptides, the I35, L36,
I39, and L40 Cα’s show significant intensity differences between
control spectra (S0) measured without
19F pulses and dipolar-
dephased spectra (S) measured with 19F pulses (Fig. 2 A and C),
indicating that the cholesterol tail lies close to these Cα atoms.
Similar dephasing was observed for both M2W andM2U, indicating
that the CRAC sequence motif is not required for cholesterol
contact to the protein. However, in TM peptides lacking the am-
phipathic helix, I35 and L36 show negligible intensity differences
between the control and dephased spectra, indicating loss of cho-
lesterol binding. This is consistent with previous thiol-disulfide ex-
change data of the TM peptide that showed limited cholesterol
binding (21). Finally, V28 and A29 in the AH-containing M2W
peptide show weak dephasing by fluorinated cholesterol. These two
residues lie at similar depths in the N-terminal leaflet of the bilayer
as the depths of I39 and L40 in the C-terminal leaflet; thus, the weak
REDOR dephasing indicates that cholesterol binds only the
C-terminal half of the TM helix, near the amphipathic helix. This
cholesterol proximity is further supported by significant dephasing of
I35, L36, I39, and L40 sidechains, in contrast to the negligible
dephasing of V28 and A29 side chains (Fig. 2).
The fraction of protein carbons in close proximity to choles-
terol is obtained from the lowest REDOR intensity ratios be-
tween the 19F-dephased and control spectra. Importantly, in the
17 mol%-cholesterol membrane, the REDOR dephasing curves of
both M2W and M2U peptides decayed to a normalized intensity
(S/S0) of only 0.5–0.6 instead of 0 (Fig. 3A), indicating that only
∼50% of the protein 13C labels are close to a cholesterol chain.
Control experiments on 5-19F-tryptophan gave the expected
REDOR dephasing to ∼0 (Fig. S1C), confirming that the incom-
plete dephasing of M2 results from partial occupancy of cholesterol
per M2 monomer. This unexpected half-occupancy in fact lies
within the previously reported range of 0.5–0.9 cholesterol per
monomer of Weybridge M2 based on tritium-labeling and filipin-
staining experiments (9). In addition, electron paramagnetic reso-
nance experiments of M2 peptides with AH spin labels in mem-
branes that contain 20 mol% cholesterol detected the coexistence
of a broad, rigid component (∼57%) and a narrow, mobile com-
ponent, indicating two distinct conformational states of the protein,
also consistent with substoichiometric cholesterol binding.
Extraction of Protein–Cholesterol Distances. Quantitative M2–cho-
lesterol distances were extracted from the mixing-time–dependent
REDOR intensity ratios (S/S0) in two steps. We focus on the Cα
dephasing, since the backbone structure of the Udorn TM–AH
peptide in lipid bilayers has been reported while the side-chain
rotameric conformations are not yet known (22). We approximated
each CF3 group as a single pseudofluorine (pF) atom, since the
dipolar coupling of a 13C atom to a fast-rotating CF3 group can be
calculated based on the motional symmetry (Methods). This sim-
plified the consideration of a 13C spin coupled to two CF3 groups to
a three-spin system containing one 13C and two pF atoms. Fur-
thermore, when a carbon atom is more than ∼6 Å away from the
center of the two methyl groups, the REDOR dephasing mainly
depends on the distance R0 (Fig. 3B) and not on the incident angle
of the carbon relative to the pF–pF vector (Fig. S2). In the first step,
we simulated the REDOR dephasing curves of one Cα coupled to
two pF atoms of a single cholesterol molecule, and scaled the
resulting curves by 0.5 to reflect the 1:2 binding stoichiometry. This
analysis yielded distances of 7–10 Å for the four Cα’s from I35 to
L40, while V28 and A29 showed distances longer than 11 Å.
In the second step, we searched a (50 Å)3 cube surrounding the
TM–AH structure (PDB ID code 2L0J) at 0.5-Å resolution to find
cholesterol tail positions that agree with the four Cα–(pF)2 dis-
tances to within ±1 Å. This search restricted the cholesterol iso-
octyl tail to the exterior of the four-helix bundle, adjacent to the
TM helices, while locations inside the pore were readily ruled out
by the REDOR data (Fig. S3). Since two cholesterol molecules bind
each tetramer (Fig. 3B), we considered simultaneous dephasing of
each Cα by four pF atoms. The two cholesterol molecules can
bind the tetramer in either a proximal or a diagonal configuration
(Fig. 3 C and D). Since the measured 13C signals are the average
of four carbons for each residue, we simulated the REDOR
curves of all four Cα carbons of each labeled site and averaged
these to obtain the final calculated REDOR curves, which were
compared with the experimental data. These calculations yielded
closest-approach Cα–pF distances of 7.0–7.1 Å for L36 and I39,
while I35 and L40 Cα show closest distances of 8.6 and 9.2 Å,
respectively (Fig. 3A and Table S2). The proximal and diagonal
binding modes gave indistinguishable REDOR curves and are
thus both possible from these data.
These protein–cholesterol distances were corroborated by 2D
13C–13C correlation spectra of 25,26,27-13C–labeled cholesterol
Fig. 1. Strategy for determining the cholesterol-binding structure of M2.
(A) Amino acid sequences of Weybridge and Udorn M2, showing the CRAC
motif residues (red) in M2W and its loss in M2U (blue). (B) Cholesterol la-
beled with 19F, 13C, and 2H for determining cholesterol binding to M2. (C)
SSNMR structure of Udorn M2(22–62) (PDB ID code 2L0J). Cα atoms whose
distances to cholesterol were measured are shown as balls, and the putative
CRAC residues are shown as sticks.
























(Fig. 1B) in M2U-containing membranes. At a mixing time of 1.0 s
and with 38-fold sensitivity enhancement by dynamic nuclear po-
larization (23), the I39 Cα and Cγ2 atoms exhibit cross-peaks with
13C-labeled cholesterol C26 and C27 (Fig. S4). These cross-peaks
were absent at short mixing times and absent in samples with un-
labeled cholesterol, confirming the assignment. The I39-cholesterol
cross-peaks have ∼70% of the intensities of an intramolecular G34–
I39 cross-peak, which corresponds to a 9.0-Å distance. Given the
1:2 binding stoichiometry of cholesterol to M2, the cross-peak in-
tensities suggest ∼8-Å distances between cholesterol 26,27-13C and
I39 carbons. G34 and A29 do not exhibit cross-peaks to cholesterol,
consistent with the 13C–19F REDOR data. The agreement between
the 13C–13C cross-peaks and the 13C–19F REDOR data also con-
firms that fluorination does not affect cholesterol binding to M2.
Additionally, at the protein monomer:lipid:cholesterol (P:L:C)
molar ratio of 1:10:2, the average distance between the edges of two
TM tetramers is ∼20 Å; thus, the cholesterol distances of 7–9 Å to
TM residues is not due to confinement of cholesterol to in-
sufficiently solvated M2 tetramers.
Determination of M2-Bound Cholesterol Orientation. In addition to
the distance constraints, we measured the sterol orientation of
bound cholesterol using 2H NMR of deuterated cholesterol (Fig.
1B). Cholesterol undergoes fast uniaxial diffusion around the bi-
layer normal at ambient temperature, giving motionally averaged
2H quadrupolar couplings that reflect the C–D bond orientations
from the bilayer normal. The 2H spectra of d6-cholesterol in the
presence of M2 show three resolved quadrupolar splittings, whose
distribution is similar to spectra of cholesterol in protein-free mem-
branes (Fig. 4A). Since the sterol rings are rigid, these splittings can
be assigned based on the fixed relative orientations of the six C–D
bonds (24, 25). The observation of only three resolved splittings for
the six C–D bonds indicates that some C–D bonds have similar
orientations to the bilayer normal. Simulation of the 2H spectra
allowed the determination of the sterol ring orientation, which was
found to be approximately vertical in the membrane, with a polar
angle β of 11° and an azimuthal angle γ of 10° for the bilayer normal
in a molecule-fixed coordinate system (Fig. 4C). Deviation from
these angles by just a few degrees result in simulated spectra that are
clearly incompatible with the experimental spectra (Fig. S5).
The absence of a second set of quadrupolar couplings and the
similarity of the 2H NMR line shapes of peptide-containing and
peptide-free membranes indicate that bound and free choles-
terol adopt similar orientations at the concentration of 17–
44 mol% in the membrane. For peptide-free membranes, the
best-fit cholesterol orientation has β = 11° and γ = 8° (Table S3).
However, the quadrupolar couplings are slightly larger in the
presence of M2 than in its absence. This difference is indicated
by the molecular order parameter Smol, which describes choles-
terol wobbling from the bilayer normal. The Smol value is 0.85 for
the peptide-free sample, in good agreement with the literature
(25), and increases to 0.89 for M2-containing membranes, in-
dicating that the degree of cholesterol wobbling is restricted by
the protein. This is supported by the d7-cholesterol
2H spectra
(Fig. 4B), which show that the 25-2H quadrupolar coupling is
broadened by M2W and increased by M2U compared with the
peptide-free spectrum. Thus, M2 partially immobilizes both the
sterol rings and the isooctyl tail.
Distance- and Orientation-Constrained Cholesterol Docking Structure
to M2. To obtain energetically reasonable structures of the M2–
cholesterol complex that incorporate these distance and orien-
tational constraints, we docked cholesterol in vacuo onto the
Udorn M2 tetramer using Autodock (26). The REDOR distance
constraints were implemented by restricting the cholesterol
C25 within a steep Gaussian potential imposed about a central
point calculated from the (50 Å)3 grid for each helix. The side-
chain χ1 and χ2 angles of I39, I42, L43, L46, and F47 were
allowed to freely rotate during docking. The docking results were
screened based on the calculated (β, γ) angles of the sterol rings;
only results that were closest to the experimentally measured
orientation were selected.
Each docked cholesterol molecule binds at the vertex between
two subunits (Fig. 5 A and C), along the C-terminal half of the TM
helix. The sterol plane is roughly tangential to the TM helix, with
the methyl-rich rough β face apposing the methyl-rich Ile and Leu
side chains from residues 35–43, forming favorable van der Waals
interactions, while the smooth α face points to membrane phos-
pholipids (Fig. 5B). Many docking results can be ruled out due to
sterol plane orientations that are incompatible with the 2H NMR
Fig. 2. Double-quantum (DQ)-filtered 13C spectra and representative REDOR spectra of M2 bound to POPC:POPG (4:1) bilayers containing F7-cholesterol.
(A) M2W(22–61) with pairwise 13C-labeled residues at I35/L36, I39/L40, V28/A29. The P:L:C molar ratio is 1:10:2. Top row: 13C spectra. Middle row: Cα
J-decoupled REDOR spectra (control S0; dephased S; difference ΔS) at 8.0-ms mixing. Bottom row: Side-chain DQ-filtered REDOR spectra at 6.4-ms mixing. (B)
TM peptide (22–46) with 13Cα-labeled I35 and L36. P:L:C = 1:10:2. The rows are the same as in A. (C) M2U(22–61) peptide with 13C-labeled A29, G34, L36, and
I39. P:L:C = 1:10:2. Top row: DQ-filtered spectrum. Bottom row: Cα J-decoupled REDOR spectra with 16.0-ms mixing. L36 Cα shows S/S0 = 0.57. (D) REDOR
S0 and S spectra of M2U(22–61) at P:L:C = 1:10:8 with 19.2-ms mixing. At this higher cholesterol concentration, L36 Cα shows a lower S/S0 of 0.45, indicating
increased cholesterol binding. All REDOR spectra were measured at 235 K under 5-kHz MAS.
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data (Fig. 5C). The CF3 groups lie at the depth of L36 while the
hydroxyl group lies near the amphipathic helix, in close proximity
to the F47 ring, thus explaining a previously observed cross-peak
between cholesterol C3 and a Phe side chain (11). Each choles-
terol molecule contacts the same subunit’s TM residues and the
beginning of the amphipathic helix, but the sterol head may also
be stabilized by polar and aromatic interactions with the neigh-
boring subunit’s R61, and the aromatic residue 57. The side-chain
conformations of AH residues are currently unknown, but rota-
meric flexibility and backbone structural adjustments may facili-
tate protein interactions with the sterol head. These multiple
stabilizing interactions with two neighboring amphipathic helices
explain the requirement of the AH for M2–cholesterol interaction
and the loss of cholesterol binding to the TM peptide. The bound
cholesterol is far from Y52 and residue 54, which is Arg in
Weybridge M2 and Phe in Udorn M2, consistent with the CRAC
independence of cholesterol binding. The similarity of bound- and
free-cholesterol orientations suggests that M2 co-opts the natural
tendency of cholesterol, but uses two AHs and the surface of one
TM helix to sequester the ligand.
Discussion
The above data show that, with 17 mol% cholesterol in the
membrane, cholesterol and M2 form a 1:2 complex. This sub-
stoichiometric binding provides crucial insights into how choles-
terol promotes membrane scission by M2. For a 1 cholesterol:2
protein complex, the proximal binding configuration is statistically
twice as likely as diagonal. The higher probability of the proximal
configuration attracts the M2–cholesterol complex to the edge of
the budding virus, because the virus lipid envelope is far more
enriched in cholesterol than the host membrane (27); moreover,
the inner leaflet of the host membrane is deficient in cholesterol
compared with the outer leaflet while the virus envelope has
similar cholesterol levels in both leaflets (28). Thus, in a host
membrane with emerging viruses, a significant lateral and longitu-
dinal cholesterol concentration gradient exists, and the proximal
M2–cholesterol complex would cluster the M2 tetramers to the
Fig. 3. M2–cholesterol distance extraction. (A) Carbon–fluorine REDOR dephasing of Cα sites in M2W, M2U, andM2TM peptides. I35, L36, I39, and L40 Cα in M2(22–
61) peptides show significant dipolar dephasing by F7-cholesterol, while V28 and A29 show minimal dephasing. I35 and L36 Cα in M2TM also show negligible
dephasing. Best-fit dephasing curves for the proximal (red) and diagonal (green) binding models are both shown. (B) Geometry of a peptide 13C spin near two CF3
groups of cholesterol. Cholesterol can bind in either a proximal mode or a diagonal mode to the tetramer. (C) Top view of the proximal and diagonal binding modes.
The CF3 groups are shown in magenta. (D) Side view of the CF3 positions in the proximal binding mode, showing the height of the cholesterol tail relative to the TM
helices.
Fig. 4. Orientation of M2-bound cholesterol. (A)
Measured (black) and best-fit simulation (red) of 2H
spectra of d6-cholesterol at 278 K in the presence
and absence of M2U(22–61). (B) 2H spectra of d7-
cholesterol. (C ) Best-fit orientation of M2-bound
cholesterol relative to the bilayer normal, calcu-
lated using a C3–OH affixed coordinate system.
























boundary between the host membrane and the budding virus (29)
(Fig. 5D). Concentrated at this interface, M2 tetramers induce
membrane curvature because the wedge-shaped four-helix bundle
excludes different amounts of volume in the two lipid leaflets (30),
the insertion of the amphipathic helix into the cytoplasmic leaflet
of the host membrane can induce stacking defects (31), and
cholesterol binding to the inner leaflet on the side of the amphi-
pathic helix can amplify the preexisting line tension at the phase
boundary (31, 32) (Fig. S6). Confocal microscopy data of fluo-
rescently tagged GUVs containing sphingomyelin, phosphocho-
line, and cholesterol showed that M2 clusters at the interface
between the cholesterol-rich liquid-ordered (Lo) and cholesterol-
poor liquid-disordered (Ld) phases (8). The current data indicate
that this interfacial location of M2 is promoted by cholesterol
binding to the tetramers in a proximal manner. At the edge of the
budding virus, the multiple curvature-inducing effects can act in
concert to excise the cholesterol-rich phase from the host mem-
brane, in excellent agreement with the observed outward budding
of the Lo phase from GUVs (8, 33).
The 1:2 binding stoichiometry found at 17 mol% membrane
cholesterol, where virus budding is active, reflects the equilib-
rium of cholesterol binding to M2, with an estimated dissociation
constant (Kd) of ∼13 mol%. When the cholesterol concentration
increased to 44 mol%, a level at which M2 no longer causes
budding (8), the REDOR intensity ratio decreased to ∼0.45 (Fig.
2D), indicating a higher binding stoichiometry. This suggests
that, when M2 resides in the cholesterol-rich virus envelope, the
population of the 1:1 complex increases, whose symmetry would
then turn off the curvature-inducing function. To verify that the
M2–cholesterol complex indeed causes curvature, we measured
static 31P-NMR spectra of the POPC:POPG membranes. Con-
sistent with previous results on virus-mimetic lipid membranes,
the spectra show a distinct isotropic peak, which is indicative of
high membrane curvature, for the 17% cholesterol membrane
(Fig. 5E and Fig. S6), but the isotropic peak is suppressed in the
44% cholesterol membrane. Thus, low cholesterol levels and
substoichiometric cholesterol binding to M2 correlate with cur-
vature generation, while high cholesterol levels and increased
binding to M2 inhibit curvature induction.
Our data show that cholesterol binding to M2 requires a
specific 3D fold instead of a specific primary sequence. The
binding-competent 3D fold is an L-shaped structure formed by
the TM helix and the amphipathic helix of the same sub unit.
The distance- and orientation-constrained structure of the M2–
cholesterol complex explains the CRAC independence of cho-
lesterol binding: the aromatic Y52 and the cationic residue 54,
which are part of the CRAC motif, are far from cholesterol (Fig.
5). This cholesterol-binding site structure differs from the other
cholesterol-docked protein structures associated with the CCM,
CRAC, and CARC motifs. While M2 utilizes a TM and a pe-
ripheral helix to form the binding pocket, the CCM motif in G-
protein–coupled receptors employs multiple TM helices (5), and
the CRAC and CARC motifs are proposed for single TM heli-
ces. The vertical orientation of M2-bound cholesterol is also
qualitatively different from the ∼45° tilted cholesterol proposed
to bind α-synuclein (7). Finally, the amyloid precursor protein
C99 uses a GXXXG motif to bind cholesterol, in contrast to the
large hydrophobic sidechains that constitute the M2–cholesterol
interface (3).
M2 is known to have pronounced conformational plasticity in
response to pH, drug, and membrane properties (34, 35), and
cholesterol is no exception. Cholesterol stabilizes M2 against
drug-induced conformational changes (11), and in cholesterol-
containing membranes the amphipathic helix adopts two confor-
mations, as shown by double electron–electron resonance EPR
measurements (36). Thus, cholesterol affects M2 structure and
dynamics in a complex fashion. The SSNMR structure of the TM–
AH peptide in cholesterol-free DOPC/DOPE bilayers (22) shows
the tetramer as a C4-symmetric bundle. In the presence of cho-
lesterol, the C4 symmetry will likely break, and the protein struc-
ture should depend on whether the complex contains proximally
or diagonally bound cholesterol. This hypothesized symmetry
Fig. 5. Structure of the cholesterol-binding site of M2. (A) Distance- and orientation-constrained docked cholesterol structure to M2. The proximal binding
model is shown. (B) Cholesterol contacts methyl-rich TM residues and is stabilized by aromatic and polar interactions with amphipathic helix residues.
(C) Representative cholesterol orientations from docking analysis and their (β, γ) angles. The (β, γ) = (24°, 17°) solution agrees with the 2H NMR data, while the
other two orientations are incompatible with the 2H NMR data. (D) Proposed model of how the M2–cholesterol complex promotes membrane curvature and
scission. M2 tetramers cluster to the neck of the cholesterol-rich budding virus because the proximal complex has a twofold higher statistical probability than
the diagonal complex. (E) Static 31P-NMR spectra of POPC:POPG:cholesterol membranes with and without M2 at varying P:L:C ratios. A strong isotopic peak
indicative of high curvature is observed in the 17% cholesterol membrane but not in the 44% cholesterol membrane.
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breaking by substoichiometric cholesterol binding, which is im-
portant for virus budding, is unrelated to the symmetry breaking
of M2 seen in cholesterol-free diphytanoylphosphocholine mem-
branes (37). Since none of the existing M2 structures were solved
in the presence of cholesterol, determining the high-resolution
structure of M2 in cholesterol-containing membranes should
allow the distinction of the proximal and diagonal binding modes
and further elucidate the molecular basis of influenza virus
budding.
Methods
M2peptides were synthesized using custom-designed fast-flow synthesizers and
Fmoc solid-phase protocols (38, 39), and were purified using reverse-phase
HPLC. Peptide purity and mass were verified using liquid chromatography
(LC)-MS. Peptides for 13C–19F REDOR experiments were dialyzed against a 1%
acetic acid solution to remove trifluoroacetate ions. Site-specifically 13C,15N-
labeled peptides were reconstituted into POPC:POPG (4:1) membranes with
varying concentrations of 19F, 13C, or 2H-labeled cholesterol (Table S1). Carbon–
fluorine distance experiments and 2H NMR experiments were mainly conducted
on a 400-MHz spectrometer, while dynamic nuclear polarization (DNP) spectra
were measured on a 600-MHz spectrometer. Methyl-rotation averaged 13C–19F
REDOR curves were simulated using the SIMPSON software and analyzed in
MATLAB, while orientation calculations were carried out in MATLAB. Choles-
terol docking to M2 was performed using Autodock 4.2. Additional details of
the experiments and data analysis are given in SI Methods.
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